Original Literature | Model OverView |
---|---|
Publication
Title
Regulation of innate immunity by suppressor of cytokine signaling (SOCS)proteins.
Affiliation
Department of Hygiene and Medical Microbiology, Institute of Hygiene, Universityof Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany.alexander.dalpke@med.uni-heidelberg.de
Abstract
Innate immunity represents the first line of defense against invading pathogens.Toll-like receptors (TLRs) are important for activation of innate immunity.Moreover, cytokines mediate communication of cells and are necessary to mount anappropriately regulated immune response. However, activation of innate immunityhas to be tightly controlled to avoid overshooting immune reactions. Suppressorof cytokine signaling (SOCS) proteins have been identified as inducible feedbackinhibitors of cytokine receptors and have been shown to be of crucial importancefor the limitation of inflammatory responses. In this review, we describe therole of SOCS proteins in macrophages and dendritic cells (DCs). Based on our ownfindings, we show that SOCS proteins are directly induced by stimulation ofTLRs. However, SOCS proteins do not interfere with direct TLR signaling, butavoid overshooting activation by regulating paracrine IFN-beta signaling. Inaddition, SOCS proteins in macrophages and DCs regulate the sensitivity towardsIFN-gamma and GM-CSF, thereby modulating anti-microbial activity of macrophagesand differentiation of DCs. We discuss that SOCS induction can also be used bymicrobes to evade immune defense, and this is exemplified by the parasiteToxoplasma gondii which induces SOCS1 to inhibit IFN-gamma-mediated macrophageactivation. Taken together, the findings indicate that SOCS proteins play animportant role in the balanced activation of innate immunity during infectiousencounter.
PMID
18406369
|
Entity
SOCS3
--
G011948
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m94757
10
infinite
0
TRANSFAC | G011948 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m29
10
infinite
0
TRANSPATH | MO000000058 |
--
MAPKs
--
MO000000077
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m69
10
infinite
0
TRANSPATH | MO000000077 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
SOCS-1
--
MO000017004
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1906
10
infinite
0
InterPro | IPR001496 |
TRANSPATH | MO000017004 |
--
SOCS-3
--
MO000017121
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2005
10
infinite
0
InterPro | IPR001496 |
TRANSPATH | MO000017121 |
--
elongin C
--
MO000018946
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m3558
10
infinite
0
InterPro | IPR001232 |
TRANSPATH | MO000018946 |
--
TLR2
--
MO000019397
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3964
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000019397 |
--
TIRAP
--
MO000022528
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m6810
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000022528 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
cytokine:Receptor:JAKs
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
Receptor:JAKs
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
cytokine:Receptor:Jaks
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
cytokine:Receptor:Jaks{active}
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
cytokine:Receptor{pY}:Jaks{active}
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m16
0
infinite
0
--
STAT dimer
--
e17
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
Cytokine:receptor{pY}:JAKs{active}:STATs
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m18
0
infinite
0
--
Cytokine:receptor{pY}:JAKs:STATs{p}
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
STAT{p} dimer
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
DNA:STATdimer
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
DNA
--
e22
cso30:c:Dna
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
mRNA
--
e23
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m23
0
infinite
0
--
LPS:TLR4
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
LPS:TLR4:TIRAP
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
LPS:TLR4:TIRAP:MyD88
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
MAPKs{active}
--
e28
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m28
10
infinite
0
TRANSPATH | MO000000077 |
--
NF-kappaB{active}
--
e29
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m30
10
infinite
0
TRANSPATH | MO000000058 |
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
proinflammatory cytokines
--
e30
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m31
0
infinite
0
--
LPS:TLR4:TRAM
--
e31
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m32
0
infinite
0
--
LPS:TLR4:TRAM:TRIF
--
e32
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m33
0
infinite
0
--
IRF-3{active}
--
e33
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m34
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
IFN-beta
--
e34
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m35
0
infinite
0
--
CpGmotif
--
e35
cso30:c:Dna
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
TLR9:CpGmotif
--
e36
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
Bacteria
--
e37
cso30:c:Cell
cso30:i:CC_Extracellular
--
csml-variable:Double
m38
0
infinite
0
--
CIS
--
e38
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m39
0
infinite
0
--
TNF-alpha receptor
--
e39
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
TNF-alpha:receptor
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
SOCS-1:JAK2:Receptor
--
e41
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m42
0
infinite
0
--
Cytokine:receptor{pY}:JAKs{active}:SOCS-2
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
SOCS-1:JAKs
--
e43
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
Cytokine:receptor{pY}:JAKs {active}:SOCS-3
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
SOCS-3:SHP-2
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
Cytokine:receptor{pY}:JAKs {active}:SOCS-3:SHP-2
--
e46
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
dergradants
--
e48
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
csml-variable:Double
m49
0
infinite
0
--
NF-kappaB{active}
--
e49
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m63
10
infinite
0
TRANSPATH | MO000000058 |
--
Cytokine
--
e5
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
Receptor
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
NF-KappaB{active}:SOCS-1
--
e64
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m65
0
infinite
0
--
SOCS:Elongin B
--
e65
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m66
0
infinite
0
--
JaKs
--
e66
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m67
0
infinite
0
--
Cytokine:receptor{pY}:JAKs{active}:CIS
--
e67
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m68
0
infinite
0
--
SOCS
--
e68
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m70
0
infinite
0
--
SOCS:ElonginC
--
e69
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m71
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
IL-6:IL-6R
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m72
0
infinite
0
--
LPS(2):TLR4(2)
--
e72
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m74
0
infinite
0
--
--
e73
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m75
0
infinite
0
--
--
e74
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m76
0
infinite
0
--
--
e75
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m77
0
infinite
0
--
microbacterial stimuli
--
e76
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m78
0
infinite
0
--
TLR3:microbacterial stimuli
--
e77
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m79
0
infinite
0
--
TLR3:miccrobial stimuli:TRIF
--
e78
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m80
0
infinite
0
--
microbial stimuli:TLR3(2)
--
e79
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m81
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
TLR2:TLR1
--
e80
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m82
0
infinite
0
--
TLR2:TLR6
--
e81
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m83
0
infinite
0
--
TLR2:TLR1:microbial stimuli
--
e82
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m84
0
infinite
0
--
TLR2:TLR6:microbial stimuli
--
e83
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
TLR2:TLR1:microbial stimuli:TIRAP
--
e84
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m86
0
infinite
0
--
TLR2:TLR6:microbial stimuli:TIRAP
--
e85
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m87
0
infinite
0
--
TLR2:TLR1:microbial stimuli:TIRAP:MyD88
--
e86
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m88
0
infinite
0
--
TLR2:TLR6:microbial stimuli:TIRAP:MyD88
--
e87
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m89
0
infinite
0
--
HPV-E7
--
e88
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m90
0
infinite
0
--
CpGmotif:TLR9(2)
--
e89
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m91
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
CpGmotif:TLR9(2):MyD88
--
e90
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m92
0
infinite
0
--
STAT{p} dimer
--
e91
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m93
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m5*m13*0.1
nodelay
--
0
PMID: 18406369 Hematopoietic cytokines act on membrane-bound receptors that lack kinase activity themselves.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m93*0.1
nodelay
--
0
PMID: 18406369 STAT dimers dissociate from the receptor and translocate to the nucleus where they act as transcription factors by binding to specific DNA sequences.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m20*m22*0.1
nodelay
--
0
PMID: 18406369 STAT dimers dissociate from the receptor and translocate to the nucleus where they act as transcription factors by binding to specific DNA sequences.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
m21*0.1
nodelay
--
0
PMID: 18406369 STAT dimers dissociate from the receptor and translocate to the nucleus where they act as transcription factors by binding to specific DNA sequences.
p13
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c32 : 1
stoichiometry:c31 : 1
m1798*0.1
nodelay
--
0
PMID: 18406369 CIS also plays a role in limiting GM-CSF, IL-2, prolactin and growth hormone signaling by inhibition of STAT5 activation.
p14
p14
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 18406369,9826711 Similar results were obtained for LPS-mediated activation of TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c119 : 1
stoichiometry:c38 : 1
m6810*m74*0.1
nodelay
--
0
PMID: 18406369 In the case of TLR2 and 4 this association is facilitated by TIR domain-containing adaptor/MyD88-adaptor-like protein (TIRAP/Mal).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m26*m1572*0.1
nodelay
--
0
PMID: 18406369 With the exception of TLR3 all TLRs use myeloid differentiation factor 88 (MyD88) as a central adaptor.
p17
p17
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c42 : 1
stoichiometry:c44 : 1
m69*m27*0.1
nodelay
--
0
PMID: 18406369 The net result is that the MyD88-dependent pathway activates MAP kinases and the NF¦ÊB signaling module
p17
p18
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m27*m29*0.1
nodelay
--
0
PMID: 18406369 The net result is that the MyD88-dependent pathway activates MAP kinases and the NF¦ÊB signaling module
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m28*0.1
nodelay
--
0
PMID: 18406369 The net result is that the MyD88-dependent pathway activates MAP kinases and the NF¦ÊB signaling module
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c3 : 1
stoichiometry:c2 : 1
m6*m67*0.1
nodelay
--
0
PMID: 18406369 However, the receptor chains are tightly associated with janus kinases (JAKs)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c129 : 1
stoichiometry:c51 : 1
m63*0.1
nodelay
--
0
PMID: 18406369 The net result is that the MyD88-dependent pathway activates MAP kinases and the NF¦ÊB signaling module
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c150 : 1
stoichiometry:c54 : 1
m19005*m74*0.1
nodelay
--
0
PMID: 18406369 TLR3 and TLR4 further bind to TIR domain-containing protein inducing IFN-¦Â (TRIF) and the latter TLR therefore uses TRIF-related adaptor molecule in addition.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m18998*m32*0.1
nodelay
--
0
PMID: 18406369 TLR3 and TLR4 further bind to TIR domain-containing protein inducing IFN-¦Â (TRIF) and the latter TLR therefore uses TRIF-related adaptor molecule in addition.
p23
p23
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m33*m977*0.1
nodelay
--
0
PMID: 18406369 TRIF in contrast mainly activates IRF3, thereby inducing IFN-¦Â, which in turn can signal in an autocrine or paracrine manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m34*0.1
nodelay
--
0
PMID: 18406369 TRIF in contrast mainly activates IRF3, thereby inducing IFN-¦Â, which in turn can signal in an autocrine or paracrine manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m36*m19828*0.1
nodelay
--
0
PMID: 18406369,11390452 Using murine macrophages and DCs, we were the first to show that triggering of TLR9 by CpG-DNA resulted in induction of SOCS1 and SOCS3
p26
p26
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c68 : 1
stoichiometry:c110 : 1
m93501*m37*0.1
nodelay
--
0
PMID: 18406369,11390452 Using murine macrophages and DCs, we were the first to show that triggering of TLR9 by CpG-DNA resulted in induction of SOCS1 and SOCS3
p26
p27
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
stoichiometry:c80 : 1
m94757*m37*0.1
nodelay
--
0
PMID: 18406369,11390452 Using murine macrophages and DCs, we were the first to show that triggering of TLR9 by CpG-DNA resulted in induction of SOCS1 and SOCS3
p28
p28
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c152 : 1
stoichiometry:c112 : 1
m94757*m74*0.1
nodelay
--
0
PMID: 18406369,9826711 Similar results were obtained for LPS-mediated activation of TLR4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m40*m230*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c10 : 1
m14*0.1
nodelay
--
0
PMID: 18406369,10071751 Upon binding of cytokines, these receptors aggregate and perform conformational changes that lead to autoactivation of the JAKs
p28
p30
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c153 : 1
stoichiometry:c111 : 1
m93501*m74*0.1
nodelay
--
0
PMID: 18406369,9826711 Similar results were obtained for LPS-mediated activation of TLR4
p31
p31
cso30:i:ME_Translation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
stoichiometry:c67 : 1
m41*m94757*0.1
nodelay
--
0
PMID: 18406369,11727828,10606755 Moreover, it turned out that also MAP-kinase activation itself The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription, or stimulation with TNF was able to induce SOCS3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c86 : 1
m28*0.1
nodelay
--
0
PMID: 18406369,11727828,10606755 Moreover, it turned out that also MAP-kinase activation itself The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription, or stimulation with TNF was able to induce SOCS3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m2004*m16*0.1
nodelay
--
0
PMID: 18406369 In turn, SOCS2 and CIS interfere with STAT recruitment PMID: 18406369 SOCS2 and CIS are assumed to mainly act by competition with STAT factors for recruitment to the activated receptor complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m2003*m16*0.1
nodelay
--
0
PMID: 18406369 In turn, SOCS2 and CIS interfere with STAT recruitment PMID: 18406369 SOCS2 and CIS are assumed to mainly act by competition with STAT factors for recruitment to the activated receptor complex.
p35
p35
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c98 : 1
stoichiometry:c97 : 1
m1906*m130*0.1
nodelay
--
0
PMID: 18406369 In contrast, SOCS1 and SOCS3 are reported to inhibit JAK activity by use of their KIR domain PMID: 18406369 However, although it has been suggested that SOCS1 directly binds to JAK2 and acts as a pseudosubstrate, it was shown that SOCS3 binds to cytokine receptor chains with special affinity for gp130.
p35
p36
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c114 : 1
stoichiometry:c104 : 1
m1807*m2005*0.1
nodelay
--
0
PMID: 18406369 In contrast, SOCS1 and SOCS3 are reported to inhibit JAK activity by use of their KIR domain PMID: 18406369 However, although it has been suggested that SOCS1 directly binds to JAK2 and acts as a pseudosubstrate, it was shown that SOCS3 binds to cytokine receptor chains with special affinity for gp130.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c100 : 1
stoichiometry:c96 : 1
m2005*m16*0.1
nodelay
--
0
PMID: 18406369 In contrast, SOCS1 and SOCS3 are reported to inhibit JAK activity by use of their KIR domain PMID: 18406369 However, although it has been suggested that SOCS1 directly binds to JAK2 and acts as a pseudosubstrate, it was shown that SOCS3 binds to cytokine receptor chains with special affinity for gp130.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m46*m16*0.1
nodelay
--
0
PMID: 18406369 In contrast, SOCS1 and SOCS3 are reported to inhibit JAK activity by use of their KIR domain PMID: 18406369 However, although it has been suggested that SOCS1 directly binds to JAK2 and acts as a pseudosubstrate, it was shown that SOCS3 binds to cytokine receptor chains with special affinity for gp130.
p39
p39
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c74 : 1
stoichiometry:c83 : 1
m93501*m38*0.1
nodelay
--
0
PMID: 18406369,12811837 In a further study, we showed that not only various TLR ligands but also whole bacteria were able to stimulate rapid production of SOCS1, -3 and CIS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
m11*0.1
nodelay
--
0
PMID: 18406369,10071751 Upon binding of cytokines, these receptors aggregate and perform conformational changes that lead to autoactivation of the JAKs
p39
p40
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c103 : 1
stoichiometry:c115 : 1
m38*m94757*0.1
nodelay
--
0
PMID: 18406369,12811837 In a further study, we showed that not only various TLR ligands but also whole bacteria were able to stimulate rapid production of SOCS1, -3 and CIS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
stoichiometry:c118 : 1
m38*m39*0.1
nodelay
--
0
PMID: 18406369,12811837 In a further study, we showed that not only various TLR ligands but also whole bacteria were able to stimulate rapid production of SOCS1, -3 and CIS
p42
p42
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c120 : 1
stoichiometry:c154 : 1
stoichiometry:c121 : 1
m130*m74*0.1
nodelay
--
0
PMID: 18406369,16287972 Recent data furthermore suggest that TLR4 stimulation might activate JAK2, thereby becoming sensitive to SOCS1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c123 : 1
stoichiometry:c127 : 1
m48*0.1
nodelay
--
0
PMID: 18406369,16415872 Meanwhile, another group suggested that TIRAP/Mal becomes poly-ubiquitinated and degraded by SOCS1, resulting in prolonged NF¦ÊB signaling
p44
p44
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c126 : 1
stoichiometry:c122 : 1
stoichiometry:c37 : 1
m1906*m6810*0.1
nodelay
--
0
PMID: 18406369,16415872 Meanwhile, another group suggested that TIRAP/Mal becomes poly-ubiquitinated and degraded by SOCS1, resulting in prolonged NF¦ÊB signaling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c128 : 1
m30*0.1
nodelay
--
0
PMID: 18406369 The net result is that the MyD88-dependent pathway activates MAP kinases and the NF¦ÊB signaling module
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c130 : 1
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m64*m63*0.1
nodelay
--
0
PMID: 18406369 Interestingly, recent results suggested that SOCS1 might be found within the nucleus where it could interact with NF¦ÊB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c134 : 1
stoichiometry:c133 : 1
stoichiometry:c135 : 1
m3559*m70*0.1
nodelay
--
0
PMID: 18406360,12076535 It was shown that the SOCS-box associates with Elongin B and C and together with cullin-2 and Rbx1 builds up an ECS-type E3 ubiquitin ligase
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c109 : 1
stoichiometry:c136 : 1
m44*m6*0.1
nodelay
--
0
PMID: 18406369 In contrast, SOCS1 and SOCS3 are reported to inhibit JAK activity by use of their KIR domain PMID: 18406369 However, although it has been suggested that SOCS1 directly binds to JAK2 and acts as a pseudosubstrate, it was shown that SOCS3 binds to cytokine receptor chains with special affinity for gp130.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c140 : 1
stoichiometry:c141 : 1
m70*m3558*0.1
nodelay
--
0
PMID: 18406360,12076535 It was shown that the SOCS-box associates with Elongin B and C and together with cullin-2 and Rbx1 builds up an ECS-type E3 ubiquitin ligase
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c106 : 1
stoichiometry:c137 : 1
stoichiometry:c138 : 1
stoichiometry:c12 : 1
m15*0.1
nodelay
--
0
PMID: 18406369 In turn, JAKs induce tyrosine phosphorylation within the receptor chains and this generates docking sites for signal transducer and activator of transcription factors (STATs)
p50
p50
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c142 : 1
stoichiometry:c143 : 1
m871*m3096*0.1
nodelay
--
0
PMISD: 18406369 Moreover, it turned out that also MAP-kinase activation itself The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription, or stimulation with TNF was able to induce SOCS3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c146 : 1
stoichiometry:c145 : 1
m72*0.1
nodelay
--
0
PMISD: 18406369 Moreover, it turned out that also MAP-kinase activation itself The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription, or stimulation with TNF was able to induce SOCS3
p52
p52
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c148 : 1
stoichiometry:c151 : 1
stoichiometry:c149 : 1
m1357*m74*0.1
nodelay
--
0
PMID: 18406369 Moreover, MAP-kinase and NF¦ÊB activation were not affected, yet STAT1 tyrosine phosphorylation upon TLR triggering was inhibited.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c78 : 1
m25*0.1
nodelay
--
0
PMID: 18406369 n turn, homo- (TLR3, 4, 9) or heterodimers (TLR1, 2, 6) are activated and associate with intracellular adaptor molecules.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c125 : 1
stoichiometry:c155 : 1
m3965*m78*0.1
nodelay
--
0
PMID: 18406369 microbial stimuli directly bind to TLRs, which results in conformational changes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c162 : 1
stoichiometry:c163 : 1
m81*m18998*0.1
nodelay
--
0
PMID: 18406369 TLR3 and TLR4 further bind to TIR domain-containing protein inducing IFN-¦Â (TRIF) and the latter TLR therefore uses TRIF-related adaptor molecule in addition.
p23
p56
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c160 : 1
stoichiometry:c161 : 1
m80*m977*0.1
nodelay
--
0
PMID: 18406369 TRIF in contrast mainly activates IRF3, thereby inducing IFN-¦Â, which in turn can signal in an autocrine or paracrine manner.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c156 : 1
stoichiometry:c157 : 1
m79*0.1
nodelay
--
0
PMID: 18406369 n turn, homo- (TLR3, 4, 9) or heterodimers (TLR1, 2, 6) are activated and associate with intracellular adaptor molecules.
p58
p58
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c165 : 1
stoichiometry:c166 : 1
m3964*m3963*0.1
nodelay
--
0
PMID: 18406369 In turn, homo- (TLR3, 4, 9) or heterodimers (TLR1, 2, 6) are activated and associate with intracellular adaptor molecules.
p58
p59
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c167 : 1
stoichiometry:c168 : 1
stoichiometry:c169 : 1
m3964*m3987*0.1
nodelay
--
0
PMID: 18406369 In turn, homo- (TLR3, 4, 9) or heterodimers (TLR1, 2, 6) are activated and associate with intracellular adaptor molecules.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m1633*0.1
nodelay
--
0
PMID: 18406369 According to recent research data , Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation?inactivation cycle, , STATs are found as pre-associated homo- or heterodimers in an anti-parallel conformation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c170 : 1
stoichiometry:c171 : 1
stoichiometry:c172 : 1
m78*m82*0.1
nodelay
--
0
PMID: 18406369 microbial stimuli directly bind to TLRs, which results in conformational changes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c173 : 1
stoichiometry:c174 : 1
stoichiometry:c175 : 1
m83*m78*0.1
nodelay
--
0
PMID: 18406369 microbial stimuli directly bind to TLRs, which results in conformational changes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c177 : 1
stoichiometry:c178 : 1
stoichiometry:c124 : 1
m85*m6810*0.1
nodelay
--
0
PMID: 18406369 In the case of TLR2 and 4 this association is facilitated by TIR domain-containing adaptor/MyD88-adaptor-like protein (TIRAP/Mal).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c176 : 1
stoichiometry:c179 : 1
stoichiometry:c180 : 1
m84*m6810*0.1
nodelay
--
0
PMID: 18406369 In the case of TLR2 and 4 this association is facilitated by TIR domain-containing adaptor/MyD88-adaptor-like protein (TIRAP/Mal).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c183 : 1
stoichiometry:c185 : 1
m86*m1572*0.1
nodelay
--
0
PMID: 18406369 With the exception of TLR3 all TLRs use myeloid differentiation factor 88 (MyD88) as a central adaptor.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c182 : 1
stoichiometry:c184 : 1
stoichiometry:c186 : 1
m87*m1572*0.1
nodelay
--
0
PMID: 18406369 With the exception of TLR3 all TLRs use myeloid differentiation factor 88 (MyD88) as a central adaptor.
p17
p66
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c187 : 1
stoichiometry:c193 : 1
stoichiometry:c194 : 1
m89*m29*0.1
nodelay
--
0
PMID: 18406369 The net result is that the MyD88-dependent pathway activates MAP kinases and the NF¦ÊB signaling module
p17
p67
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c189 : 1
stoichiometry:c197 : 1
stoichiometry:c198 : 1
m88*m29*0.1
nodelay
--
0
PMID: 18406369 The net result is that the MyD88-dependent pathway activates MAP kinases and the NF¦ÊB signaling module
p17
p68
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c188 : 1
stoichiometry:c191 : 1
stoichiometry:c192 : 1
m89*m69*0.1
nodelay
--
0
PMID: 18406369 The net result is that the MyD88-dependent pathway activates MAP kinases and the NF¦ÊB signaling module
p17
p69
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c195 : 1
stoichiometry:c196 : 1
m88*m69*0.1
nodelay
--
0
PMID: 18406369 The net result is that the MyD88-dependent pathway activates MAP kinases and the NF¦ÊB signaling module
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c17 : 1
m16*m17*0.1
nodelay
--
0
PMID: 18406369 In turn, JAKs induce tyrosine phosphorylation within the receptor chains and this generates docking sites for signal transducer and activator of transcription factors (STATs) PMID: 18406369 Upon cytokine receptor stimulation, STAT dimers change their conformation towards a parallel one and bind to tyrosine-phosphorylated cytokine receptor chains by use of their Src homology 2 (SH2) domain. PMID: 18406369 In turn, SOCS2 and CIS interfere with STAT recruitment PMID: 18406369 SOCS2 and CIS are assumed to mainly act by competition with STAT factors for recruitment to the activated receptor complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c199 : 1
stoichiometry:c200 : 1
m37*0.1
nodelay
--
0
PMID: 18406369 n turn, homo- (TLR3, 4, 9) or heterodimers (TLR1, 2, 6) are activated and associate with intracellular adaptor molecules.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c201 : 1
stoichiometry:c202 : 1
stoichiometry:c203 : 1
m91*m1572*0.1
nodelay
--
0
PMID: 18406369 With the exception of TLR3 all TLRs use myeloid differentiation factor 88 (MyD88) as a central adaptor.
p17
p72
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c204 : 1
stoichiometry:c205 : 1
stoichiometry:c206 : 1
m92*m69*0.1
nodelay
--
0
PMID: 18406369 The net result is that the MyD88-dependent pathway activates MAP kinases and the NF¦ÊB signaling module
p17
p73
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c207 : 1
stoichiometry:c208 : 1
stoichiometry:c209 : 1
m92*m29*0.1
nodelay
--
0
PMID: 18406369 The net result is that the MyD88-dependent pathway activates MAP kinases and the NF¦ÊB signaling module
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c212 : 1
stoichiometry:c211 : 1
m90*m70*0.1
nodelay
--
0
PMID: 18406369,15021916 It was reported that human papilloma virus (HPV) E7 protein could be degraded by SOCS expression, resulting in a loss of proliferation of HPV-transformed HeLa cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c19 : 1
m18*0.1
nodelay
--
0
PMID: 18406369 In turn, STATs are tyrosine phosphorylated by JAKs, which uncovers a nuclear localization signal.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c22 : 1
stoichiometry:c21 : 1
m19*0.1
nodelay
--
0
PMID: 18406369 STAT dimers dissociate from the receptor and translocate to the nucleus where they act as transcription factors by binding to specific DNA sequences.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--